Leadership rarely allows time to slow down. But this week in San Diego, senior executives from across the branded merchandise industry are doing exactly that – stepping away from day‑to‑day execution to focus on long‑term direction, shared challenge...

From AI-powered workflows to smarter e-commerce tools, technology is rapidly transforming how branded merchandise companies operate, serve customers and stay competitive. These innovations aren’t only improving efficiency but also opening new doors ...

PPAI got the ball rolling at North American Leadership Conference in San Diego on Tuesday night with a glitzy executive networking event and exclusive unveiling of the 2026 PPAI 100, held at Snapdragon Stadium.Attendees mingled in clubs and on t...

People love a challenge. That’s why office competitions, from wellness challenges to sales competitions, are so popular. People thrive on the energy and urgency, and they enjoy the bragging rights for being crowned the winner.SalesScreen’s Sindr...

STRAN (PPAI 161542, Platinum) released its public business update, which revealed that the Massachusetts-based distributor achieved $31.2 million in first quarter sales for 2026.That number represents an 8.9% year-over-year increase compa...

UPDATE: On May 12, a federal appeals court temporarily paused a lower court decision to block President Donald Trump’s 10% global tariff. The pause applied only to a handful of plaintiffs, so most businesses still owed the import tax anyway, but mor...

Advocacy for the branded merchandise industry doesn’t begin and end in Washington, D.C. Increasingly, it also happens in state capitols, regional association events and local conversations where policymakers can hear directly from the businesses tha...

Most teams have a few people who are quick to speak up — and those who barely say a thing. Staff members who tend to stay quiet may think decisions have already been made. Or maybe they’ve been talked over before and prefer to stay quiet. The proble...

The Department of Justice has officially reclassified state-licensed medical marijuana and FDA-approved cannabis products from Schedule I to Schedule III under the Controlled Substances Act – a historic shift in federal policy that could be a boon f...